{"id":"W4401715291","doi":"10.1111/bjh.19706","title":"<scp>PembroWM</scp> : A phase <scp>II</scp> trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Thomas Hospital","funders":"Merck Sharp and Dohme","keywords":"Medicine; Rituximab; Internal medicine; Chemoimmunotherapy; Tolerability; Refractory (planetary science); Oncology; Pembrolizumab; Gastroenterology; Phases of clinical research; Clinical trial; Adverse effect; Immunotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001682989,0.0003235097,0.001575589,0.0005562484,0.0001684713,0.000117575,0.0003795228,0.0003780997,0.00001866464],"category_scores_gemma":[0.007508528,0.0002776813,0.000233843,0.0006355864,0.0009572897,0.0001823962,0.0003881556,0.001507166,0.00001495466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001367444,"about_ca_system_score_gemma":0.004768613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000395656,"about_ca_topic_score_gemma":0.0001685951,"domain_scores_codex":[0.995882,0.0004790938,0.001611267,0.0005230668,0.0007340662,0.0007704874],"domain_scores_gemma":[0.9950389,0.003293836,0.000386887,0.000361624,0.000286339,0.0006324534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.03670321,0.0059278,0.0007866862,0.005845592,0.002396841,0.6552085,0.01670251,0.00009567094,0.008674497,0.003722104,0.1165527,0.1473838],"study_design_scores_gemma":[0.3486748,0.004678804,0.001327832,0.003648568,0.0004256529,0.5969172,0.000941958,0.001485599,0.002739315,0.0008081993,0.03824866,0.0001033904],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9652907,0.03116363,0.0000424275,0.001191219,0.0005304292,0.0009609089,0.000039653,0.00003249928,0.000748519],"genre_scores_gemma":[0.9939706,0.004157553,0.0004204435,0.0003413289,0.0003527382,0.00001855005,0.000007467814,0.00006574913,0.0006655866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3119716,"threshold_uncertainty_score":0.9999675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01723235397203564,"score_gpt":0.3111091422852666,"score_spread":0.2938767883132309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}